However, the clinical translation of our findings will require future research using a combination of in vivo and ex vivo work to understand the factors that restore normal platelet physiology and reduce the risk of thrombosis in the insulin-resistant type 1 diabetes population. This evidence concerns the gene INS and type 1 diabetes mellitus.